Why Today Matters

TTWO opened at $234.40 and traded down to $216.76, a 6.6% decline on 4.3 million shares with 1.8 million average.

Escalating GTA 6 footage leak rattled investor confidence in the company’s flagship upcoming title.

The leak has been running since August 18. Roughly 14 clips surfaced showing combat, driving, minigames, radio stations, and large sections of the Vice City map. Rockstar responded publicly, calling the leak heartbreaking while confirming the November 19, 2026 launch on PS5 and Xbox Series X/S is unchanged. Take-Two has since served DMCA subpoenas on Microsoft and Discord seeking account data to identify the leaker.

The Extended Look aired on Netflix on August 27 as scheduled. Shares rose roughly 2.5% on that reveal. Today gave all of it back and more.

You are being paid the elevated vol that today’s move created.

Why This Expiry

October 16 sits in a catalyst vacuum.

You collect premium on a name whose entire thesis resolves after their risk is off the table. No earnings print. No launch. No review embargo lift. No day-one server performance.

What’s left inside the window is news flow, not fundamentals: more leaks, marketing beats, sell-side notes, and macro. The kind of thing that produces 5–10% drawdowns, not 14.5% ones.

The fundamental backdrop is intact. Take-Two’s August 7, 2026 first-quarter Fiscal 2027 results reiterated the Fiscal 2027 net bookings guidance built around the launch, with the product pipeline table listing Grand Theft Auto VI for PS5 and Xbox Series X/S on November 19, 2026. Q1 FY2027 net bookings hit $1.39B against guidance of $1.32B–$1.37B, driven by NBA 2K and Grand Theft Auto outperformance, with full-year guidance reaffirmed at $8B–$8.2B and management expecting operating cash flow above $1B. The stock gained 6.0% the day after that print to close at $246.50.

The Street is aligned. The average 12-month target is $286.89 with a high of $368 and a low of $170; 28 analysts recommend buying and 1 suggests selling.

The Breakeven Is the 52-Week Low

This is the number that should decide the trade for you.

• Breakeven: $187.75

• 52-week low: $187.63 (set March 27, 2026)

• 52-week high: $265.94 (July 7, 2026)

Alt

Defined-risk alternative worth pricing: the 190/180 put spread. Selling the 190 at $2.25 and buying the 180 at $1.10 collects $1.15 and caps the loss at $8.85 per spread. You give up half the premium and eliminate the unbounded tail. Given flat skew, the 180 leg is cheap protection in relative terms.

What This Print Actually Tells You

On the worst day TTWO has had since the leaks began, someone with $87 million of capacity chose to write a nine-figure notional short put into the weakness rather than sell stock or buy protection.

You are betting that seven weeks of leak headlines, soft Circana prints, and rate anxiety cannot take Take-Two 14.5% lower to a level it hasn’t touched in a year.

The Numbers

Ross reported Q2 FY2026 on August 20 after the close. The quarter, from the 8-K:

Guidance going in was $1.85–$1.93. Consensus was $1.94–$1.95. Ross printed $2.66.

Operating margin expanded 610 basis points. 405 bps of that came from approximately $253 million in IEEPA tariff refunds, roughly $0.60 per share. Strip it out and the margin still expanded 205 bps against a plan of 130–150 bps.

First half: sales $12.275B (+17%), comps +13%, net income $1.501B, EPS $4.69 vs $3.03.

Then they raised the back half. Q3 comps +6–7% with EPS $1.75–$1.83. Q4 comps +4–5% with EPS $2.17–$2.26. Full-year FY2026 EPS moved from $7.50–$7.74 to $8.61–$8.77, against $6.61 in FY2025. Store openings went from 110 to 115.

The balance sheet at August 1, 2026: $4.288B cash against $1.019B total debt. Stockholders’ equity $6.743B. First-half operating cash flow $1.712B. They bought back 1.4 million shares for $319 million in Q2 and remain on track for $1.275B this year under a $2.55B authorization. Ex-dividend $0.445 on September 8.

An Empty Calendar

There is no earnings report before October 16. Ross reported Q2 on August 20. Q3 covers the quarter ending October 31.

Ross is a low-drama stock that detonates four times a year and drifts the rest of the time.

Removing four days a year takes 3.5 to 4 volatility points out of the stock.

The Odds

Converging estimate: 78–88% probability of keeping the full premium. 9–20% probability of a loss at expiry.

The Setup

The 860 strike sits 20.44% below spot. Net of premium, breakeven is $852.10, 21.17% below the current price, with 46 days to run.

Why to follow

The options market assigns an 11.37% risk-neutral probability of finishing below 860. Over 468 rolling 32-trading-day windows in GEV’s two-year history, only 9, 1.9%, fell 20.44% or more. You are collecting on a distribution roughly 6x wider than realized outcomes.

No earnings in the window. GEV reports Q3 on approximately October 21, nineteen days after this contract expires. One ~$0.50 dividend (ex-date mid-September) is immaterial at 0.046% of spot.

The company itself was a buyer at this level. GEV repurchased 4.3 million shares through June 30 at an average price of $854. Management raised FY2026 guidance in July to $45.5–46.5B revenue and $11.5–12.5B free cash flow, up from a prior $6.5–7.5B FCF range, with $13.1 billion of cash on hand.

Sold to open: 2,250 META Oct 2 2026 $515 puts at $5.50

Why Follow It

1. There is no earnings print in the window. Meta’s next earnings report is scheduled for October 28, 2026.

2. The strike is below the 52-week low. META’s 52-week intraday low is $520.26, set on March 27, 2026. The strike is $515. The stock has not traded at this strike, even intraday, in twelve months. Count of daily closes below $515 in the trailing year: zero.

3. The breakeven is below the panic. After the July 29 Q2 miss, reported EPS of $6.18 against consensus of $7.10, roughly a 13% shortfall, META bottomed at a $556.71 close on July 31. The $509.50 breakeven is 8.5% below the worst close of the worst print of the year. The stock has since chopped between $578 and $599 for eleven straight sessions.

4. Valuation at the strike is not heroic. Consensus FY2026 EPS is $28.50; FY2027 is $34.47.

To lose on this trade, the market has to re-rate a 25%-revenue-growth franchise to below 15x forward-forward earnings, with no catalyst on the calendar to do it with.

Dec 150 calls bought to open and Dec 245 calls sold to open for $26.50 each.

The 150s for $38.00 and the 245s for $11.50.

Why the 245 strike

Wall Street’s consensus 12-month price target on SKHY sits at $245.21 (Investing.com, 13 analysts), $244.92 (S&P Global via stockanalysis.com, 14 analysts), and $245.50 (MarketBeat and Benzinga Pro). Range: $152 low, $355 high.

You’re selling the consensus target.

The bull case

Q2 2026, reported July 29 (all figures company-reported):

• Revenue ₩79.32T, +257% YoY, +51% QoQ

• Operating profit ₩60.54T, +557% YoY, 76% operating margin

• Net profit ₩93.92T (118% net margin, including ~₩63.3T of investment gains from the Kioxia stake exit)

• One quarter’s operating profit exceeded all of FY2025’s ₩47.21T

• First-half revenue crossed ₩100T for the first time in company history

Market position: #1 in HBM at 56.4% share. #2 in DRAM at 29.1%. #2 in NAND at 18.5%. DRAM was 77.3% of Q1 sales.

Deutsche Bank models 2026 DRAM demand of 2,261k WSPM against 2,051k of capacity. By 2028: 3,563k demanded, 2,769k available, a 29% gap. Still 18% short in 2029 and 11% in 2030. Micron’s Sumit Sadana told KeyBanc’s conference this week that 2027 will be “even tighter” than 2026. Intel’s Lip-Bu Tan noted memory makers are effectively sold out for two years.

The industry has stopped behaving like a commodity. SK hynix signed long-term agreements with roughly ten major customers. Muse’s note describes contracts with volume, pricing corridors, up-front cash, and financial penalties for non-performance. That is a different business model than the one that produced a ₩9.14 trillion loss in 2023.

Guidance and capacity: Q3 DRAM shipments guided +~10% QoQ; full-year DRAM demand growth mid-20s%. HBM4 entered mass production in Q2 with yields near HBM3E maturity; HBM4E samples delivered on 1cnm. 2026 capex raised to the “high ₩40 trillion” range, with M15X and Yongin accelerated.

Valuation-consensus Q3 EPS is $6.09 per ADS. That’s $24.36, 6.8x at the ADR price. Fair multiple.

What the strikes actually require

To reach breakeven, $176.50

To reach max profit, $245

[PUTS SOLD] DELL 10/16/2026 $370 Put, 500 contracts @ $26.30

The Case For Following It

The cushion is enormous relative to the fundamental trajectory. DELL’s Q1 FY27, reported May 28, produced revenue of $43.8B (+88% y/y), non-GAAP EPS of $4.86 (+214%), AI-optimized server revenue of $16.1B (+757% y/y), $24.4B in AI orders booked, and a record $51.3B AI backlog across more than 5,000 AI customers. Management guided full-year revenue to $165–169B with roughly $60B of AI server revenue.

The strike sits below every published target on the Street. Barclays $550, Goldman $500, Evercore $500, Bernstein $500, Morgan Stanley $477, Citi $475. Consensus clusters near $489. The 370 strike is roughly 24% below where the average analyst thinks the stock trades in twelve months.

88.95% implied is 21 vol points above the trailing one-year realized of 68.05%. If volatility mean-reverts toward its own annual average, this put is meaningfully overpriced. Repricing the option at 68.05% vol gives a theoretical value of $14.58 versus the $26.30 collected.

Earnings

DELL’s Q2 FY27 report is estimated for August 27, 2026. Consensus sits at $4.84 EPS on $44.80B of revenue, against $2.32 and $29.78B a year ago.

DELL’s recent earnings reactions have been violent in both directions. The five largest single-day moves in the last 60 sessions: +28.34%, +15.50%, +10.17%, +9.09%, −10.32%.

[PUTS SOLD] NVDA Sep 4, 2026 $190 puts 13,000 contracts @ $1.90

The Case for Following It

1. The cushion is wide

• Strike sits 13.44% below spot

• Breakeven at $188.10, 14.30% below spot

Over the trailing twelve months, exactly 1 of 231 rolling 21-trading-day windows produced a decline of 13.44% or worse. That’s 0.4%. The worst 21-day peak-to-close drawdown in that stretch was −15.0%.

2. The structure fits the setup

Short a 12-delta put into a name with a 20.7x–24.0x forward multiple, a 0.47 PEG, 114% ROE, and guidance for roughly $91.0 billion in quarterly revenue after posting $81.6 billion last quarter. If assigned, the entry is $188.10, a level NVDA last traded above sustainably before the current leg.

The Catch: August 26

This trade is short a put through earnings. NVDA reports Q2 FY2027 on August 26 after the close, nine days before the September 4 expiry.

To breach $188.10, NVDA needs roughly 2.5x the implied earnings move, or a normal sized miss followed by sustained selling into the first week of September.

14,250 contracts of the CCJ September 11, 2026 $70 puts sold at $0.58.

The Calendar

Cameco reported Q2 2026 on Friday, July 31. The stock traded a $83.93–$91.41 range that day and closed at $86.38.

There is no scheduled Cameco earnings report between now and September 11 expiry.

What Q2 Actually Said

The headline was a miss. Adjusted EPS of $0.13 against a $0.26 consensus. The stock sold off.

Underneath:

• Revenue $814 million, down 7% year-over-year, but ahead of consensus

• Net earnings $25M; adjusted net earnings $77M; adjusted EBITDA $391M

• Uranium production 3.9M lb, down 15% YoY on spring road conditions in northern Saskatchewan

• Sales 7.1M lb at an average realized price of $93.13/lb, up 15% year-over-year

• Produced-and-purchased cash cost $55.84/lb

• 2026 production guidance reaffirmed at 19.5–21.5M lb

• Guidance raised for 2026 uranium realized price and consolidated revenue

The EPS miss is overwhelmingly a Westinghouse story. Cameco’s share of Westinghouse adjusted EBITDA fell to $163M from $352M a year ago, and Westinghouse swung to a $10M net loss from a $126M profit. Westinghouse contributes roughly 25% of Cameco’s EBITDA annually, so the swing dominates the print, but it is not the uranium business deteriorating. The uranium business sold fewer pounds at meaningfully better prices.

On the same day, Westinghouse confidentially filed a draft Form S-1 with the SEC for a proposed IPO. Cameco owns 49%, Brookfield Renewable 51%. Share count and price range are undetermined. Desjardins characterized the timing as several years ahead of expectations. Whatever it eventually prints at, a Westinghouse listing is a mark-to-market event on the least transparent asset on Cameco’s balance sheet, and it lands as a potential catalyst in exactly the window this option covers.

The Commodity Didn’t Break — The Multiple Did

CCJ is 34% below its 52-week high. It is not bc of a uranium collapse.

The physical proxy is up on the year. The equities de-rated. TradeTech’s long-term price indicator hit $93.00/lb on March 31, the highest level in more than 18 years. Cameco’s own realized price rose 15%. What compressed was the multiple investors were willing to pay for nuclear adjacent equities after a January melt up, not the underlying commodity economics.

The Base Rate

The option is priced at a 10.3% risk-neutral probability of finishing below $70. What does 25 years of Cameco actually say?

The market is charging roughly 10.3% for an outcome that has occurred 2.4–2.9% of the time over a quarter century. That is a 3.5–4x markup on the empirical tail.

Layered on top: the $70 strike is not an arbitrary number. CCJ’s 52-week intraday low is $68.96 and its 52-week closing low is $70.47 (August 20, 2025). The last time Cameco closed below $70 was June 23, 2025, more than thirteen months ago. The $69.42 breakeven sits between the 52-week closing low and the 52-week intraday low. Wall Street’s lowest published price target on the name is $81.99, against a consensus of roughly $133–138 across 23–25 analysts. UBS upgraded to Buy with a C$166 target, explicitly calling the selloff a buying opportunity.

Sold to open: 3,545 CDNS September 18, 2026 $270 puts at $3.15.

Premium collected $1,116,675 Distance to breakeven −20.61% Days to expiration 46

No earnings in the window

Cadence reported Q2 2026 on Monday, July 27: revenue of $1.58 billion, up 24.2% year over year, non-GAAP EPS of $2.11 against a $2.05 consensus, net margin of 21.18% and ROE of 28.44%. Management raised FY2026 guidance to $8.05–$8.15 EPS on roughly $6.3 billion of revenue at the midpoint, and guided Q3 to $2.01–$2.07.

You are writing a 46-day contract that contains zero scheduled company-specific catalysts. Guidance was just raised eight days ago.

Win rate

Over the trailing two years, I ran every overlapping 46-calendar-day window in CDNS, 470 of them:

• 9 windows (1.9%) closed down 19.61% or more.

• 22 windows (4.7%) touched −19.61% at any point intraperiod.

• Mean 46-day return: +2.75%. Median: +1.08%.

• 5th percentile: −14.74%. Worst: −27.91%.

Black-Scholes at 52.58% IV assigns a 13.46% probability of finishing in the money. The two-year empirical frequency is 1.9%. Even accounting for the fact that overlapping windows understate independence, that is a wide gap.

Running the actual payoff across all 470 historical windows applied to today’s spot:

• Expected P&L: +$2.95 per contract, +$1,044,855 on the position

• Historical win rate: 98.5%

5,570 contracts of the AAPL $280 put expiring October 16, 2026, sold at $3.80 per contract.

Why the $280 Strike Is Not Random

Three things converge at this level:

1. The 200-day moving average sits at roughly $275 - almost exactly the $276.20 breakeven. The seller loses money only if AAPL breaks its long-term trend line and keeps going.

2. $280.14 was the post-Q2-earnings close on May 1- the level the market validated after Apple’s best-ever March quarter ($111.2B revenue, EPS $2.01 vs. $1.94 expected, Greater China +28% YoY).

3. The expiry threads the earnings calendar. Oct 16 expiration captures the July 30 Q3 report but expires before the October Q4 report.

Why Follow

• One earnings event, well-telegraphed. Apple guided Q3 revenue growth of 14–17% YoY (~$110B) with 47.5–48.5% gross margins. The company has beaten EPS consensus four straight quarters. Consensus sits at $1.88–1.89.

• 14.8% of cushion in 86 days on a stock that just reclaimed the title of world’s most valuable company and sits 3.2% below its all-time high of $334.99.

Sold to open: 800x AVGO $300 puts, November 20, 2026 expiration, at $15.00

• Premium collected: $1,200,000

• Breakeven: $285.00

• Days to expiration: 126

Why the Seller Likes This

1. Fundamental momentum is extraordinary. Q2 fiscal 2026 revenue came in at $22.19 billion, up 47.9% year over year, with non-GAAP EPS of $2.44 marking the eighth consecutive quarterly EPS beat, and AI semiconductor revenue of $10.80 billion, up 143%. Q3 revenue guidance is $29.4 billion, and CEO Hock Tan is still targeting $100 billion in AI chip revenue in 2027.

2. The Apple overhang is gone. Broadcom locked in Apple as a customer through 2031, erasing the in-sourcing fear that drove the post-earnings drop, and the deal is worth roughly $30 billion.

3. The cushion is substantial. The stock has to fall 18.9% just to reach the strike and 23.0% to reach the $285 breakeven. Breakeven sits only $12 above the $273 52-week low set on July 23, 2025. The seller loses money only if AVGO trades essentially back to its worst level of the past year, after the Apple deal, after two more quarters of triple-digit AI growth.

4. Street support. 26 analysts carry a consensus Buy rating with an average 2026 price target of $501.58, and Morgan Stanley reaffirmed its Buy on July 14, calling AVGO a core AI winner.

Why Follow This Trade

This is a textbook institutional short put: At a psychologically and technically significant strike, struck below the post-earnings panic lows, at an IV in the mid-50s that prices in substantially more turbulence than a business guiding to $29.4 billion next quarter would ordinarily warrant.

Sold to open: 1,300 AMZN Sep 18, 2026 $200 puts @ $2.30

• Premium collected: $299,000

• Breakeven: $197.70

• Days to expiration: 63

With AMZN trading at $245.76, this seller is committing to buy Amazon nearly 19% below the current price and getting paid about $300K for it.

Probability of finishing ITM at expiration: ~12.3% at the current mid, ~13.7% at the fill’s implied vol. This is roughly a 1-in-7 assignment probability trade with an 86–88% win rate on the binary outcome.

Bull Case -Why the Seller Wins

The cushion is huge. AMZN would need to fall 18.6% just to reach the strike and 19.6% to breach breakeven, a drawdown that would take the stock below its 52-week low of $196. Short puts on quality mega-caps at strikes below the annual low have historically been one of the highest win-rate income structures available.

LITE (Lumentum Holdings): 800 of the $540 puts sold to open, expiration September 18, 2026 for $42.50 each.

The Math That Makes This Attractive

1. A 29% margin of error. Breakeven is $497.50 ($540 strike − $42.50 premium). LITE must fall 29.0% from here before the seller loses a dollar at expiration. The strike itself sits 22.9% below spot.

2. Risk-neutral probability of expiring worthless: ~66%. And that’s using the option market’s own 103% vol assumption. If you believe realized vol going forward will be lower than 103%, plausible, since triple-digit IV is pricing near-crash conditions continuously, the true odds are better.

3. The vol regime is the edge. You’re being paid because IV is 103%. Selling puts is fundamentally a short-volatility trade, and this is one of the richest vol surfaces available on a profitable, index-relevant large cap right now.

4. Fundamental floor arguments. LITE has grown revenue roughly 69% this year, supplies optical components into AI/ML infrastructure through its Cloud & Networking segment, and carries a consensus Buy from 24 tracked analysts: 19 buy/strong buy, 5 hold, zero sells, with a 12-month median target of $1,100. Stifel favors Lumentum in the optical components sector, and Jensen Huang has publicly backed optical connectivity, with Nvidia committing $6.5B to photonics to address AI’s interconnect bottleneck. A $540 assignment price would represent a ~50% discount to the June high and roughly 6x below where the sell side pegs fair value.

Risks

• One earnings report sits inside the window. LITE reports on August 11, 2026. A guidance miss on co-packaged optics timing could gap this stock 20–30% overnight. It fell from $814 intraday yesterday to $700 today with no earnings.

Other Ways to Follow

The institutional trade is naked/cash-secured short puts. Sized-down equivalents:

• Cash-secured: 1 contract = $54,000 secured, $4,250 collected

• Defined risk: a 540/490 put credit spread caps assignment risk at around $4,000 width per spread while keeping most of the theta, and eliminates the tail scenario.

Verdict

This is a paid-to-wait trade with an unusually wide moat: 23% OTM cushion, 29% breakeven buffer, and a fundamental backdrop where the entire sell side is above the current price and the strongest player in AI infrastructure is investing directly into the seller’s thesis. The bet: LITE doesn’t give back more than half of its AI rally in the next 64 days. At 103% implied vol, that’s a bet worth following.

Catalysts and timeline

• Q2 2026 earnings land inside the window. This is the single largest known driver of the elevated IV.

• SHW most recently reported Q1 2026 on April 28: EPS $2.35 vs. $2.26 expected, a beat. Full-year guidance stands at adjusted EPS $11.50–$11.90 (GAAP $10.70–$11.10).

• Management’s own framing has been a softer-for-longer demand environment, with low-single-digit raw-material (resin/pigment, tariff) inflation and 80–100 net new store openings planned.

• Trades around recent SHW prints: the stock has shown earnings-day moves in the −2% to −5% range and traded a $301.58–$376.94 band in the months after its January report, relevant context for gap risk against a $296.50 breakeven.

If SHW clears the July print without breaching the breakeven, the back ~3–4 weeks of the trade benefit from both the post-earnings IV crush and accelerating theta.

The bull case — why follow it

1. A 12.5% cushion to a level that has held.

2. Time is the tailwind. Decay is the dominant P&L driver if the stock is range-bound.

3. Built-in IV-crush catalyst. The elevated IV is partly the Q2 event premium. Surviving the late-July print collapses that premium in the seller’s favor.

4. High base-rate odds. The contract is structured to expire worthless in the large majority of outcomes.

PUTS SOLD CEG 7/31/26 $210 put 4,130 contracts @ $1.50 Premium collected: $619,500

This is a bullish-to-neutral position. The seller keeps the full $619,500 as long as Constellation Energy (Nasdaq: CEG) closes above $210 on July 31. They only take stock if CEG falls more than 17% in the next 31 days.

Where CEG actually sits

CEG is down roughly 38% from its $412.70 peak last October. The $210 strike sits 17.2% below today’s spot and 12.7% below the existing 52-week low.

The de-rating was a multiple unwind:

• The business beat. Q1 2026 (reported May 11) delivered adjusted EPS of $2.74 against roughly $2.53–$2.60 consensus, on revenue of $11.12B and net income of $1.59B.

• The Calpine deal closed. The $16.4B acquisition completed January 7, 2026, creating a ~55 GW, coast-to-coast fleet that is roughly two-thirds carbon-free, the largest private-sector power producer on the planet.

• Capital return. A $5B buyback is authorized; management guides $8.4B of free cash flow across 2026–27, rising to $11.5–13.0B by 2028–29.

The stock is down bc there were two things the market wanted and didn’t get. The March 31 outlook initiated full-year 2026 EPS guidance of $11.00–$12.00, below the ~$11.72 Street estimate, and no new hyperscaler power-purchase agreement was announced. Then a slipped restart timeline at the Crane (Three Mile Island) unit tied to the 20-year Microsoft PPA, a $5B forced divestiture of 4.4 GW of gas capacity to LS Power to clear regulators, and a Fed that removed its easing bias in mid-June (higher-for-longer rates compress every long-duration growth multiple). The result: NTM EV/EBITDA fell from roughly 20.5x at the 2025 peak to ~11.7x today, essentially in line with the ~11.8x peer mean.

The froth is gone. What’s left is a question of whether the growth re-rates.

The bull case for the short put

1. The strike is more than a standard deviation away.

2. The expiry is before the earnings event.

3. You’re selling vol at a premium to medium-term realized. Model IV of ~50% sits above 30/60/90-day realized of 46.2% / 46.6% / 49.1%, and well above the cooled 20-day realized of 33.9%. Theta works in the seller’s favor.

4. The valuation reset has already happened. At spot, CEG trades ~22x the midpoint of its own $11–12 guide; assignment at $208.50 implies ~18x forward earnings on a business management says can compound base EPS ~20% through 2029. You’re being paid to set a limit buy at a price that is not demanding.

5. There’s a live, un-priced catalyst. ~147 million MWh of clean, firm nuclear output remains uncontracted for 2030. Any new hyperscaler PPA is upside the market has explicitly stopped paying for, and a buyback provides a bid underneath the stock while you wait.

Bottom line

The setup is coherent and high-probability: a structurally advantaged business that’s already given back a third of its value, sold to a strike that requires a new low inside a 31-day window with no earnings.

The case for following it

1. The cushion is enormous. A 34.2% buffer to breakeven over 52 days is a wide margin of safety in absolute terms.

2. You’re harvesting rich, well-executed volatility. For the seller to lose, realized volatility has to stay extreme and point downward. Premium sellers win when implied exceeds realized; at triple-digit IV, that’s a high bar for the stock to clear against them.

3. The fundamentalS. Q1 2026 revenue was $113.6M, up 88% year over year; FY2025 came in at $326.7M, up 61%; the Communications, Enterprise & Datacenter business has now logged seven straight quarters of triple-digit YoY growth, explicitly AI-driven per management.

Puts Sold- SMH 7/2/26 $440P ~30,000 contracts @ $0.62

A single block sold roughly 30,000 weekly $440 puts on the VanEck Semiconductor ETF (SMH) for $0.62, collecting $1.86M in premium on a strike sitting 28.4% below spot with six days to expiration. This is a sale of the far tail of the volatility skew.

SMH is hugging a flat 20-day SMA after pulling back from the $668.91 June 22 high, riding well above a rising 50-day SMA. The $440 strike is a full 28.4% below spot and beneath every close in the last six months.

What the seller is actually doing

This is a deep-OTM skew harvest. Back out implied volatility from the $0.62 fill via Black-Scholes inversion (model-derived, not vendor-reported):

The seller is monetizing the gap between what the market charges for crash insurance 28% OTM (126.9% vol) and what SMH has actually delivered (47–66% realized). The position wins if that insurance expires worthless, which requires SMH to not fall 28.5% in six trading days.

Greeks

The seller is structurally long delta, short gamma, short vega, positive theta, the textbook premium-seller profile, but with delta near zero because the strike is so far out.

Economics & decay path

Holding spot and IV constant, the put decays:

Roughly 80% of the premium is captured in the first three days. The trade is front-loaded. It works fastest if nothing happens.

Bull case — why the trade works

• Distance. $440 is below the entire six-month range. SMH would need a 28.5% collapse in six sessions, far beyond its 66.3% 20-day realized vol, which implies a ~7+ sigma move to touch breakeven.

• Trend intact. Price above a rising 50-day SMA; the pullback held the 20-day. No structural break.

• Skew premium. Selling 126.9% vol against 47–66% realized is a wide cushion. The seller is paid for tail risk that has not materialized.

• Theta dominance. Six days, deep OTM, gamma and vega risk only matter near the strike, which is 28% away. Time decay is the dominant Greek.

The setup

CBRE is the world’s largest commercial real-estate services firm (>$155B AUM, #1 in leasing, sales, outsourcing, property management, valuation). Fundamentally it is not deteriorating: Q1 2026 Core EPS of $1.61 beat the $1.13 estimate by 42%, revenue rose 19% to $10.5B, and management guides FY26 Core EPS to $7.30–$7.60 (~17% growth). That puts the forward multiple near ~18x, undemanding for a double-digit grower.

The stock, however, has de-rated: down ~21% from the $174 high, currently sitting right on its 50-day ($137) but well below a declining 200-day ($150).

The income / bull case

1. The strike is below the 52-week low. $115 sits beneath the $121.69 floor of the past year. For the put to finish in-the-money, CBRE must fall ~16% and print fresh 52-week lows.

2. Positive vol-risk premium. 40% implied vs ~30% realized, the seller is paid for volatility that, historically, hasn’t shown up.

3. ~80–88% probability of full premium capture, depending on whether you weight risk-neutral or realized-vol odds.

4. Theta works, and accelerates. ~84 days sits in the steepening part of the decay curve.

5. Quality underlying. A profitable, growing market leader at ~18x forward.

Bottom line

This is a volatility-premium harvest with a quality, below the 52 week low and ~80–88% odds of full capture. The July 28 earnings print inside the window, and CBRE’s demonstrated ability to gap ~20% on that print.

Sold to open: 10,500× MU Jul-2-2026 $675 put @ $1.20

This trade was yesterday, but still like it.

The cushion is the trade

Micron is in a vertical, textbook-bullish trend. The moving-average stack is fully stacked bullish (price > 20-day > 50-day > 100-day):

The strike sits between the 50- and 100-day moving averages. For these puts to even reach the money, Micron would have to fall ~43% in six trading days — not just below its 20- and 50-day averages, but all the way back to roughly its 100-day line, erasing about three months of trend in a week.

The bull case for following it

1. A 43% air pocket below spot.

2. They’re selling into rich, skewed vol.

3. Decay is front-loaded in the seller’s favor.

Bottom line

The institution is doing the right trade: a 98%-probability, post-earnings vol harvest with a 43% cushion. The setup is real, the cushion is enormous, and the decay is in the seller’s favor.